Kato Ikuko, Dyson Gregory, Snyder Michael, Kim Hyeong-Reh, Severson Richard K
Department of Oncology, Wayne State University School of Medicine, Detroit, USA; Department of Pathology, Wayne State University School of Medicine, Detroit, USA.
Department of Oncology, Wayne State University School of Medicine, Detroit, USA.
J Radiat Oncol. 2016 Sep;5(3):279-286. doi: 10.1007/s13566-016-0245-8. Epub 2016 Jan 27.
The objective of this study was to investigate whether cancer specific survival in rectal cancer patients is affected by patient-related factors, conditional on radiation treatment.
359 invasive rectal cancer patients who consented and provided questionnaire data for a population-based case-control study of colorectal cancer in Metropolitan Detroit were included in this study. Their vital status was ascertained through to the population-based cancer registry. Hazard ratios (HR) for cancer specific and other deaths and 95% confidence intervals (CIs) were calculated according to selected patients' characteristics, stratified by radiation status, using joint Cox proportional hazards models.
A total of 159 patients were found to be deceased after the median follow-up of 9.2 years, and 70% of them were considered to be cancer specific. Smoking and a history of diabetes were associated with an increased probability of deaths from other causes (HR 3.20, 95% CI 1.72-5.97 and HR 2.02, 95% CI 0.98-4.16, respectively), while regular use of non-steroidal anti-inflammatory drugs (NSAIDs) was inversely correlated with cancer-specific mortality (HR 0.50, 95% CI 0.30-0.81). Furthermore, the associations of smoking and NSAIDs with the two different types of deaths (cancer vs others) significantly varied with radiation status (P-values for the interactions= 0.014 for both). In addition, we observed a marginally significantly reduced risk of cancer specific deaths in the patients who had the relative ketogenic diet overall (HR=0.49, 95% 0.23-1.02).
Further research is warranted to confirm these results in order to develop new interventions to improve outcome from radiation treatment.
本研究的目的是调查在接受放射治疗的前提下,直肠癌患者的癌症特异性生存率是否受患者相关因素的影响。
本研究纳入了359例浸润性直肠癌患者,这些患者同意并为底特律大都会地区一项基于人群的结直肠癌病例对照研究提供了问卷数据。通过基于人群的癌症登记处确定他们的生命状态。使用联合Cox比例风险模型,根据选定的患者特征,按放射状态分层,计算癌症特异性死亡和其他死亡的风险比(HR)及95%置信区间(CI)。
在中位随访9.2年后,共发现159例患者死亡,其中70%被认为是癌症特异性死亡。吸烟和糖尿病史与其他原因导致的死亡概率增加相关(HR分别为3.20,95%CI为1.72 - 5.97和HR 2.02,95%CI为0.98 - 4.16),而经常使用非甾体抗炎药(NSAIDs)与癌症特异性死亡率呈负相关(HR 0.50,95%CI 0.30 - 0.81)。此外,吸烟和NSAIDs与两种不同类型死亡(癌症与其他)的关联因放射状态而有显著差异(两者的相互作用P值均为0.014)。另外,我们观察到总体采用相对生酮饮食的患者癌症特异性死亡风险略有显著降低(HR = 0.49,95%为0.23 - 1.02)。
有必要进行进一步研究以证实这些结果,从而开发新的干预措施来改善放射治疗的效果。